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 Abstract 
Chloroplast transformation technology has emerged as an alternative platform offering 
many advantages over nuclear transformation. SAG1 is the main surface antigen of the 
intracellular parasite Toxoplasma gondii and a promising candidate to produce an anti-T. 
gondii vaccine. The aim of this study is to investigate the expression of SAG1 using 
chloroplast transformation technology in tobacco plants. In order to improve its expression 
in transplastomic plants, we also expressed the 90-kDa heat shock protein of Leishmania 
infantum (LiHsp83) as a carrier for SAG1 antigen. SAG1 protein accumulation in 
transplastomic plants was approximately 0.1-0.2 µg per gram of fresh weight (FW). Fusion 
of SAG1 to LiHsp83 significantly increased the level of SAG1 accumulation in tobacco 
chloroplasts (by up to 500-fold). We also evaluated the functionality of the chLiHsp83-
SAG1. Three human seropositive samples reacted with SAG1 expressed in transplastomic 
chLiHsp83-SAG1 plants. Oral immunization with chLiHsp83-SAG1 elicited a significant 
reduction of the cyst burden that correlated with an increase of SAG1-specific antibodies. 
We propose the fusion of foreign proteins to LiHsp83 as a novel strategy to increase the 
expression level of the recombinant proteins using chloroplast transformation technology, 
thus addressing one of the current challenges for this approach in antigen protein 
production. 
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 1 Introduction 
Plants have demonstrated the ability to produce functionally active proteins from 
mammals or other eukaryotic organisms with therapeutic activity, such as human serum 
and growth regulatory proteins, antibodies, antigens, hormones and cytokines [1, 2]. 
Despite providing many beneficial properties for protein production such as scalability, low 
production costs and in the case of vaccine production absence of pathogenic contaminants, 
one of the major challenges for the use of plants as an alternative expression system is the 
relatively low expression yields of recombinant proteins [3].   
The stability of plant-derived recombinant proteins is considered the predominant 
factor that limits protein yields achieved by molecular farming [4]. In the past few years, 
chloroplast transformation technology has emerged as an alternative platform that offers 
many advantages over nuclear transformation such as high levels of transgene expression 
due to high copy number, transgene containment via maternal inheritance of plastids and 
multi-gene expression in a single transformation event [5, 6]. However, previous studies 
have also shown that, for certain eukaryotic proteins, chloroplast transformation has only 
provided a limited expression yield [7-11]. In this sense, new strategies should be explored 
in order to improve the production yield of foreign proteins expressed in plants and increase 
the commercial potential of plant-based production systems.  
SAG1 is the main surface antigen of the intracellular parasite Toxoplasma gondii, 
the causal agent of toxoplasmosis [12, 13]. In human, toxoplasmosis is usually 
asymptomatic in healthy individuals. However, in pregnant women, congenital infection 
can cause severe neonatal malformations [14]. Although a vaccine against human infection 
with T. gondii is not yet available, an effective vaccine against toxoplasmosis may be 
valuable to prevent both fetal infection and reactivation. In this context, numerous studies 
 have established the potential of SAG1 as a candidate to produce an anti-T. gondii vaccine 
[15-21]. Previous attempts to express SAG1 using various classical heterologous 
expression systems have been challenged by low expression levels or poor antigenicity of 
the recombinant SAG1 protein [22-27]. SAG1 is thus both a promising antigen for vaccine 
development, and a good candidate to optimize an antigen production strategy using an 
alternative protein expression system such as plant-based protein production [26, 27]. 
The heat shock proteins belonging to the 90-kDa family (HSP90) are highly 
conserved among bacteria, yeast, plants, and animals [28]. HSP90s function as molecular 
chaperones to prevent inappropriate associations or aggregations of partially folded proteins 
[29]. In addition, HSP90s promote cell survival in response to many forms of cellular stress 
[30]. In general, HSP90s are ubiquitously expressed at high levels, with HSP90s making 
between 1 and 2% of total soluble proteins [31]. We hypothesize the high level of 
constitutive HSP90 expression combined with its chaperone properties may be utilized to 
enhance the expression of recombinant proteins in plants by using HSP90 as a carrier 
protein and by expressing recombinant proteins of interest as HSP90 fusion proteins. 
Previously Echeverria et al. [32] demonstrated that the 90-kDa heat shock protein of 
Leishmania infantum (LiHsp83) is a good candidate to carry Toxoplasma antigens 
produced as recombinant proteins in bacteria. Therefore, within this study we use LiHsp83 
as a carrier for T. gondii SAG1 antigen in order to improve its expression in transplastomic 
plants. Our findings show that fusion of SAG1 to LiHsp83 significantly increases the level 
of SAG1 accumulation in tobacco chloroplasts.  
 
 2 Material and Methods 
2.1 Vector construction 
The vectors pAF-SAG1and pAF-LiHsp83:SAG1 were constructed as previously described 
[11, 34, 35] with slight modifications. The SAG1 sequence was amplified by polymerase 
chain reaction (PCR) from the pRSET-SAG177-322 vector [33] using the primers 5’-
cccgggCACTTCACTCTCAAGTGCCC-3’ (upstream, lowercase indicates SmaI restriction 
site) and 5’-ctcgagAGCAAAGATGGAAACATGAG-3’ (downstream, lowercase indicates 
XhoI restriction site). The SAG1 fragment was cloned into the vector pAF-TDHIS to 
generate the plasmid pAF-SAG1 as was previously described by [11]. The LiHsp83 
sequence was amplified by PCR from the pQ-LiHsp83 vector [36] using the primers 5’-
cccgggACGGAGACGTTCGCGTTCCAG-3’ (upstream, lowercase indicates SmaI 
restriction site) and 5’-gttaacGTCCACCTGCTCCATGCTGG-3’ (downstream, lowercase 
indicates HpaI restriction site). The LiHsp83 fragment was digested with SmaI and HpaI 
restriction enzymes and cloned into the pAF-SAG1 plasmid digested by SmaI, to give 
plasmid pAF-LiHsp83:SAG1.  
 
2.2 Transformation and regeneration of transformed chloroplast plants 
In vitro-grown tobacco (Nicotiana tabacum cv. Petite Havana) leaves were 
transformed by bombarding pAF-SAG1 or pAF-LiHsp83:SAG1 plasmids-coated gold 
particles using the PDS1000/He (Bio Rad, Hercules, CA) biolistic device, as previously 
described [11, 37]. Leaves were then cut into small pieces and placed on regeneration 
RMOP medium containing 500 mg/L spectinomycin [11, 37]. After 2 cycles of shoot 
regeneration, the regenerated plants were moved to a greenhouse for homoplasmy 
confirmation and seed production.  
 2.3 Southern blot analysis 
Ten µg of plant DNA was digested with BglII, separated on a 0.8% (w/v) agarose 
gel and transferred on to a nylon membrane. The digestion by BglII and BamHI of the 
chloroplast vector generated a 0.8-kb probe (P1) homologous to the flanking sequences 
(Figure 1A). Probe labelling, hybridization and detection were performed as previously 
described [11]. Homoplastic plants were grown in a greenhouse for further analysis.  
 
2.4 Protein Extraction 
Leaves from transplastomic plants and wild-type tobacco plants were ground in 
liquid nitrogen. For total protein extraction, 100 mg of grounded leaves were homogenized 
in 300 µl Laemmli buffer (0.5 M Tris–HCl pH 6.5, 4% SDS, 20% glycerol, 10% β-
mercaptoethanol and 0.1% bromophenol blue). The total protein content was measured 
using the RC-DC protein assay (Bio Rad) with BSA as a standard according to the 
manufacturer’s instructions.  
To separate soluble and insoluble protein fractions, powdered leaves (100 mg) were 
homogenized in 500 μL of protein extraction buffer (20 mM NaPO4, 250 mM NaCl, 0.1% 
Triton X-100) [11, 38] and sonicated for 15 s. After centrifugation at 13,000 rpm, Laemmli 
buffer was added to soluble fraction (supernatant) and insoluble fraction (pellet). 
  
2.4 SDS-PAGE and Western blot analysis 
Leaf protein extracts were heated at 100°C for 5 min and separated by 10% 
(chLiHsp83-SAG1) or 15% (chSAG1) SDS-polyacrylamide gels which were either stained 
with coomassie brilliant blue or transferred onto PVDF membrane (GE Healthcare) using 
 an Electro-transfer unit (Bio Rad). The membranes were ncubated with rabbit anti-SAG1 
polyclonal antibody (1:500) or rabbit anti-LiHsp83 polyclonal antibody (1:500) followed 
by anti-rabbit IgG alkaline phosphatase conjugate as secondary antibody (1:5000; Sigma). 
Phosphatase activity was detected using NBT/BCIP substrate (Promega, Fitchburg, WI). 
The accumulation of recombinant proteins (chSAG1 and chLiHsp83-SAG1) in tobacco 
leaves was estimated by comparing plant extract samples with a serial dilution of known 
concentration of E. coli-purified SAG1 (EcSAG1) [33], or E. coli-purified LiHsp83 
(EcLiHsp83) [39] electrophoresed on the same polyacrylamide gel. The band intensity of 
purified EcSAG1 and EcLiHsp83 detected by Western blot was estimated with the “Gel-
Pro analyzer” software (Media Cybernetics, Rockville, MD) and used as a standard to build 
a calibration curve as previously described [11, 27]. The leaf-expressed chSAG1 band 
intensity detected by Western blot was estimated using the “Gel Pro analyzer” software and 
compared with a calibration curve obtained by the band intensity of EcSAG1, while the 
leaf-expressed chLiHsp83-SAG1 band intensity was compared with two calibration curves 
obtained from the band intensity of EcSAG1 or from the band intensity of EcLiHsp83. 
Exclusively the intact band detected by Western blot was taken into account to estimate the 
chSAG1 and chLiHsp83-SAG accumulation. This analysis allowed us to have an 
estimation of the concentration of chSAG1 and chLiHsp83-SAG1 expressed in chloroplast 
transformed plants.  
 
2.5 Reactivity of human serum samples 
Human serum samples were obtained during routine serologic screening of pregnant 
women at Parasitology Department, ANLIS “Dr. Carlos G. Malbrán”, Argentina, and 
analyzed by IgG-Indirect immunofluorescence assay (IFA) and in-house IgM-ISAGA test. 
 Two of the three positive sera used in this study were grouped as IgG+, IgM- and 
the other was grouped as IgG+, IgM+. Three seronegative samples (IgG-, IgM-) were used 
as negative control. The use of these serum samples was approved by the Independent 
Ethics Committee for the Medical Federation of Buenos Aires Province, Argentina 
(FE.ME.BA., note 592, September 23rd, 2014).  
Leaf extract samples were separated by 10% SDS-PAGE under reducing conditions 
and transferred onto PVDF membrane (GE Healthcare). Human serum samples were 
assayed at 1:100 dilution. Phosphatase alkaline conjugated anti-human IgG was used as 
secondary antibody (1:2500; Sigma). The reaction was developed by the addition of 
NBT/BCIP substrate (Promega). Pre-stained proteins (Fermentas, Waltham, MA) was 
included in Western blots as molecular weight marker. 
 
2.6 Oral immunization of mice 
Female C57BL/6 (H-2b) mice were obtained from the Biotechnology Research 
Institute (IIB), National University of General San Martin (UNSAM), Buenos Aires, 
Argentina. The mice were bred and housed according to institutional guidelines approved 
by the Independent Ethics Committee for the Care and Use of Experimental Animals of the 
National University of General San Martin (C.I.C.U.A.E., IIB-UNSAM, 09/2011). 
Lyophilized plant leaf stocks were used for oral administration to 8- to 10-wk-old 
mice as previously performed [11]. The leaf extracts was homogenized in PBS 1X buffer. 
The chLiHsp83-SAG1 group received five doses of transplastomic leaf extracts (4-6 µg of 
chLiHsp83-SAG1), at one-week intervals, while the control group received five doses of 
 wild-type leaf extracts. A PBS group was also included. This group was orally immunized 
with five doses of PBS buffer.  
 
2.7 Measurement of antibody responses 
Antigen-specific antibodies were analyzed by enzyme linked immunosorbent assay 
(ELISA) as previously described [11, 26, 27]. Two weeks after the last immunization, 
blood was collected from the tail vein and sera were stored at -20°C until the antibody 
response analysis. Briefly, microtiter plates (Immuno Plate Maxiorp; Nunc, Roskilde, 
Denmark) were coated with rSAG1 (5 µg/ml, EcSAG1). Rat anti-mouse immunoglobulin G 
(IgG)-horseradish peroxidase conjugate (1:3000) was used as a secondary antibody 
(Sigma). Immune complexes were revealed with TMB (Invitrogen, Waltham, MA) and 
optical density was read at 650 nm with an automatic ELISA reader (Synergy H1, Bio-Tek, 
Winooski, VT). Serum samples were used at a 1:100 dilution. Pre-immune serum samples 
were used as negative controls.  
 
2.8 Challenge infection 
Two weeks after the last immunization, mice (eight per experimental group) were 
orally infected with 20 Me49 tissue cysts (sublethal dose) as previously achieved [11, 27]. 
One month after the challenge, animals were sacrificed and their brains removed for tissue 
cyst quantification. The mean number of cysts per brain was determined under an optical 
microscope, by counting four samples of each homogenized brain. 
 
2.9 Statistical analysis 
 Statistical analysis was carried out with the Prism 5.0 Software (GraphPad, La Jolla, 
CA) using one-way analysis of variance (ANOVA). A Bonferroni’s test was used to 
compare means. P < 0.05 was considered significant. 
 
 3 Results 
3.1 Cloning of SAG1 and LiHsp83-SAG1 fusion constructs 
The SAG1 and LiHsp83-SAG1 sequences were fused to the promoter and 5′-
untranslated region of the psbA gene (PpsbA) with a downstream box composed by the first 
15 codons of the green fluorescence protein (GFP15) [34, 40] and to the tetramerization 
domain (TD) from the human transcription factor p53, inclusion of which has previously 
been demonstrated to favor the accumulation of antigenic peptides in tobacco chloroplasts 
[34]. Finally, a 6xHis-tag was included at the C-terminal region of the recombinant proteins 
(Figure 1A). The expression cassettes were inserted between the trnI and trnA genes into 
the chloroplast genome (Figure 1A).  
 
3.2 Conﬁrmation of transgene integration in transplastomic plants 
The pAF-SAG1 and pAF-LiHsp83:SAG1 constructs were introduced into Nicotiana 
tabacum cv. Petite Havana chloroplasts by biolistic transformation [37]. Stable integration 
of transgenes into the chloroplast genome and homoplasmy of the transformed plants were 
confirmed by Southern blot analysis (Figure 1B). A 4.5-kb DNA fragment was detected in 
wild-type chloroplasts, whereas transformed chloroplasts released two DNA fragments 
either of 5.2 and 1.8-kb (for SAG1 plants) or 5.2 and 3.7-kb (for LiHsp83-SAG1 plants) 
(Figure 1A, B). The absence of 4.5-kb bands in the transformed lines indicates 
homoplasmy.  
 
3.3 Morphology of transplastomic plants 
After rooting on Murashige and Skoog medium, transgenic plants were transferred 
to the greenhouse for seed production and morphological studies. SAG1 transplastomic 
 lines exhibited normal growth and morphology. In contrast, LiHsp83-SAG1 transplastomic 
lines showed stunted growth during both in vitro and greenhouse conditions. Moreover, 
leaves from all transplastomic LiHsp83-SAG1 plant lines were chlorotic and pale in color 
as compared to wild-type tobacco plants, and this phenotype persisted in the successive 
generations (Figure 2). Despite the stunted growth and chlorotic leaf phenotype of the 
LiHsp83-SAG1 transplastomic plants, they reached maturity, produced fertile seeds and 
yielded the same amount of seeds that are usually produced in wild-type plants. 
 
3.4 Expression and quantiﬁcation of the SAG1 protein  
The expression of SAG1 in transformed plastome (chSAG1) was detected by 
Western blot using an anti-SAG1 polyclonal antibody. A faint 34-kDa band was observed 
in total protein extracts obtained from mature leaves of transplastomic plants grown for 90 
days after transplantation (Figure 3A). In addition to the 34-kDa band, other nonspecific 
signals were present in both SAG1 transplastomic plants and wild-type tobacco plants. As 
expected, the chSAG1 migrated at a slower rate on the gel compared to the E. coli-derived 
SAG1 (EcSAG1) due to the N- and C-terminal fusions mentioned above (Figure 3).  
To determine the levels of chSAG1 expression, plant tissue was lyophilized with the 
final weight reduced to 10-fold relative to the initial fresh weight (10X). The chSAG1 
expression levels were then estimated by Western blot with an anti-SAG1 polyclonal 
antibody using a dilution series of EcSAG1 as reference (Figure 3B). The accumulation of 
chSAG1 protein in transplastomic plants was approximately 1-2 µg per gram of lyophilized 
weight (LW) that represents 0.1-0.2 µg per gram of FW.  
 
3.5 Expression and quantification of LiHsp83-SAG1 fusion protein 
 We also investigated whether utilization of LiHsp83 as a carrier of SAG1 can 
improve the protein expression in transplastomic plants.  When 25 µg of total protein from 
leaf extract was resolved by SDS-PAGE, a band of corresponding size to the chLiHsp83-
SAG1 fusion product could be observed upon staining with coomassie blue. This band of 
approximately 130-kDa was absent in wild-type tobacco plants and it was clearly visualized 
in samples obtained at 50, 75 and 100 days after transplantation (Figure 4A). Samples of 
LiHsp83-SAG1 transplastomic plants showed a decrease in the intensity of the band 
corresponding to the large subunit of pro-homeostatic RuBisCo enzyme with respect to the 
wild-type tobacco plants at each 50, 75 and 100 days after transplantation.  
The 130-kDa band was excised from the gel and analyzed by MALDI-TOF/TOF, 
which revealed several peptides (22% sequence coverage) that matched with chLiHsp83-
SAG1 fusion sequence (Figure S1). In addition, Western blot analysis with an anti-LiHsp83 
or an anti-SAG1 polyclonal antibody revealed the 130-kDa band expected for chLiHsp83-
SAG1 fusion protein (Figure 4A). A second specific band of approximately 100-kDa was 
also revealed by both antibodies. This secondary band is probably a degradation product of 
chLiHsp83-SAG1 fusion protein. Finally, multiple bands with lower molecular weight 
were only detected by anti-LiHsp83 antibody suggesting that these bands are N-terminal 
degradation products due to these bands were not detected by anti-SAG1 antibody (Figure 
4A).  
In order to evaluate the solubility of the fusion protein, total soluble and insoluble 
proteins were extracted from developed mature leaves. The speciﬁc 130-kDa band was 
observed mainly in the soluble fraction in 50 and 100-day-old plants by coomassie blue 
staining (Figure 4B).  
 3.6 Effect of leaf age on LiHsp83-SAG1 expression 
To determine whether the leaf age affects the expression level of the recombinant 
fusion protein, transplastomic plants were grown in the greenhouse for 100 days and 
analyzed. The total protein content is normally higher in young and mature leaves than in 
old leaves because of higher proteolytic activity in senescent leaves [41]. Usually, the 
profiles of recombinant proteins matched those of the total protein content [41]. Contrary to 
expectation, the expression level of chLiHsp83-SAG1 in young leaves was barely 
detectable by coomassie blue staining (Figure 5A). However, we observed that the fusion 
protein mainly accumulated in mature and old leaves (Figure 5A).  
ChLiHsp83-SAG1 accumulation in mature and old leaves was estimated by 
Western blot analysis using EcSAG1 and EcLiHsp83 for reference as described in Material 
and Methods (Figure 5B). The relative amount of chLiHsp83-SAG1 fusion protein 
accumulated in transplastomic plants was up to approximately 100 µg per gram of FW 
(~2.5% of total cellular proteins) (Figure 5B). We estimated the yield of chLiHsp83-SAG1 
expressed in tobacco chloroplast according to the number and weight of mature and old 
leaves per plant (2.8 g of FW/leaf). A total of 3.6 mg of chLiHsp83-SAG1 could be 
produced per plant, the great majority of this coming from mature and old leaves. 
 
3.7 Antigenicity and immunogenicity analysis of the chLiHsp83-SAG1 
In order to evaluate the antigenic functionality of the chLiHsp83-SAG1, the 
reactivity of human serum samples against SAG1 was analyzed by Western blot under 
reducing conditions. A total of six human serum samples (3 positive and 3 negative sera) 
were tested. A band around 130-kDa (chLiHsp83-SAG1 protein) was detected by the 
positive serum samples. In addition, these positive sera reacted with other band around 100-
 kDa. This lower band was also detected by the rabbit anti-SAG1 antibody that was used as 
positive control (Figure 6A). Immunoblot analysis using samples extracted from wild-type 
plants and EcLiHsp83 protein did not show reactivity with any of the positive serum 
samples (Figure 6B and C). 
In order to study the immunogenicity of the chloroplast-made LiHsp83-SAG1, we 
included an oral immunization protocol using C57BL/6 (H-2b) mice. Lyophilized material 
was used for oral administration to mice (Figure S2). The amount of chHsp83-SAG1 
protein was estimated to be 200 µg/g of lyophilized weight (Figure S2).  
Mice were orally immunized with lyophilized LiHsp83-SAG1 leaves (LiHsp83-
SAG1 group) or lyophilized wild-type leaves (control group). Mice orally immunized with 
PBS buffer were also included as an additional control (PBS group). Two weeks after last 
immunization, mice were challenged with cysts from T. gondii M49 strain [11, 27]. A 
month later, the number of T. gondii brain cysts was analyzed. The LiHsp83-SAG1 group 
showed a significant reduction in the cysts (57%) compared to both control and PBS groups 
(Figure 7A). In addition, humoral response was determined by ELISA using rSAG1. Two 
weeks after the immunization protocol was finished, serum samples were taken from 
immunized mice. LiHsp83-SAG1 group showed a significant increase of SAG1-specific 
IgG antibodies compared to control and PBS groups (Figure 7B). 
 
 4 Discussion 
4.1 LiHsp83 protein used as a carrier improve the expression of T. gondii SAG1 
antigen in the chloroplast 
SAG1 is well conserved at the immunological and amino acid sequence levels 
making it an attractive antigen for diagnostics and immunoprophylaxis of Toxoplasmosis 
[42]. For this reason, this protein has been produced using a variety of expression systems 
[22-27]. The SAG1 expression using eukaryotic cell systems, such as Pichia pastoris [43, 
44] or CHO cells [45], resulted in an hyper-glycosylation of the protein (N- and O-
glycosilation) that affected its immunogenicity [44]. Since Toxoplasma, like other 
Apicomplexans does not have N-glycosylation, the chloroplast expression would offer the 
unique chance to express properly folded non-glycosylated SAG1 protein featuring the 
native amino acid sequence, which is not possible in the other eukaryotic expression 
systems like P. pastoris or CHO cells. In the present study, we investigated chloroplast 
transformation technology as a method to improve the SAG1 expression. In addition, 
SAG1 was fused to L. infantum Hsp83 as a strategy to enhance recombinant protein 
stability.  
SAG1 transplastomic lines exhibited normal growth and morphology. In contrast, 
LiHsp83-SAG1 transplastomic lines showed chlorosis and growth retardation. Several 
publications have previously reported changes in the phenotype of transplastomic plants [9, 
46]. Some of these reports suggest that the potential causes of the phenotypes observed 
include recombinant protein interference in different metabolic processes or/and the effect 
of transgene over-expression by itself [46].  In our case, other possible explanation for the 
phenotypic changes observed in LiHsp83-SAG1 transplastomic plants could include 
potential disruption of chloroplast Hsp90 function. Chloroplast Hsp90 (Hsp90C) plays an 
 important role in chloroplast biogenesis [47, 48]. hsp90C mutant in Arabidopsis, alters 
responses to red light and delays chloroplast development [47]. More recently, Feng et al. 
[48] showed that the co-suppression of Hsp90C cause albino phenotypes in seedlings of 
Arabidopsis down-regulating the expression of genes involved in photosynthesis. 
According to these antecedents, it remains to be determined whether chLiHsp83-SAG1 
fusion protein is competing with Hsp90C for the binding to co-chaperones or client proteins 
affecting the normal phenotype of plants.  
In previous reports, we determined that it was feasible to produce the T. gondii 
SAG1 protein in plants of Nicotiana spp. by means of transient expression via recombinant 
A. tumefaciens [26, 27]. We demonstrated that codon sequence optimization showed a 
negative impact on protein yield, while endoplasmic reticulum (ER) targeting improved the 
native SAG1 protein expression reaching yields of approximately 1.3 μg per gram of fresh 
weight (FW) [27]. Here, the relative amount of SAG1 protein accumulated in 
transplastomic plants was approximately 0.1-0.2 µg per gram of fresh weight (FW). These 
expression levels of chSAG1 were lower to those obtained by previous studies that utilized 
vacuum agroinfiltration method for SAG1 expression in tobacco leaves [26, 27]. Laguía 
Becher et al. [27] reported that ER localization allow the accumulation of SAG1 (~1.3 μg 
per gram of FW) to levels higher than that achieved by chloroplast transformation. The 
higher levels of expression yield achieved in these studies may be attributable to ER that 
provides a relatively protective environment with molecular chaperones and stabilizing 
agents. Similar to studies examining exogenous expression of SAG1 in plants, Bellucci et 
al. [49] demonstrated that the plant storage protein zeolin also exhibits reduced 
accumulation when expressed from the chloroplast genome compared to the targeting of the 
recombinant protein to the ER. Bellucci et al. [49] suggested that higher levels of 
 proteolytic activity present within the chloroplast may account for the reduced zeolin 
stability compared to the ER accumulation.  According to this report we hypothesize that, 
for some specific proteins, targeting to ER provides a better protective and stabilizing 
environment than expression in the chloroplast, resulting in increased SAG1 stability and 
an enhanced level of SAG1 accumulation.  
The yields of many proteins that have shown to be difficult to produce in 
chloroplasts have also been shown to accumulate at higher concentrations when fused to 
carrier proteins [8, 35, 41, 50]. These findings suggest that the carrier protein would act to 
stabilize the recombinant protein expressed in chloroplasts and may also protect against 
proteolysis. Here, we expressed LiHsp83 to function as a carrier for SAG1 antigen in order 
to improve its expression in transplastomic plants. Fusion of SAG1 to LiHsp83 
significantly increased the level of SAG1 accumulation in tobacco chloroplasts (by up to 
500-fold). In addition, chLiHsp83-SAG1 protein accumulation does not decrease 
significantly as the plant ages, although the peak yield would appear to be at 75 days after 
transplantation, and also highlights a greater stability than the non-fusion SAG1. Also 
samples of LiHsp83-SAG1 transplastomic plants showed a decrease in the intensity of the 
band corresponding to the large subunit of pro-homeostatic RuBisCo enzyme with respect 
to the wild-type tobacco plants at each 50, 75 and 100 days after transplantation. This is 
consistent with findings from Bally et al. [51, 52], who demonstrated that the over-
expression of recombinant proteins in chloroplasts commonly resulted in reduced 
expression of endogenous proteins including RuBisCo. However, in our case it remains to 
be elucidated whether the reduction of RuBisCo observed in LiHsp83-SAG1 
transplastomic plants is due to direct interference of the recombinant protein, as it was 
already mentioned above. 
 The relative amount of chLiHsp83-SAG1 fusion protein accumulated in 
transplastomic plants was up to approximately 100 µg per gram of FW (2.5 % of total 
protein), the majority of which was observed in the soluble protein fraction. These results 
show that fusion of SAG1 to LiHsp83 significantly increased the level of chSAG1 
accumulation in tobacco chloroplasts. Since chSAG1 and chLiHsp83-SAG1 are 
synthesized from the same expression cassette, we infer that the low levels of chSAG1 
expression are not due to inefficient transgene transcription or translation. In addition, 
accumulation of the chLiHsp83-SAG1 recombinant fusion protein was found to be higher 
in plant tissues (mature and old leaves) with higher levels of proteolytic activity. Given that 
HSP90s are highly stable in different stress conditions, in addition to the functions of 
HSP90s in promoting correct protein conformation [53, 54], our results suggest that the 
fusion of SAG1 to the molecular chaperone LiHsp83 promotes SAG1 stabilization and/or 
protects it from degradation. Similarly, using tobacco plant chloroplasts, Sanz-Barrio et al. 
[55, 56] found improved expression and solubility of recombinant human serum albumin 
(HSA) when fused or co-expressed with thioredoxin f, a plastidic oxidoreductase with 
chaperone-like properties. Together, these findings support the use of molecular chaperones 
as carriers to improve the expression yield and solubility of recombinant proteins in 
chloroplasts. 
 
4.2 LiHsp83-SAG1 fusion protein retain the immunogenic and antigenic properties of 
T. gondii SAG1 antigen 
In order to determine if an antigenic SAG1 version is expressed in LiHsp83-SAG1 
transplastomic plants, the reactivity of human serum samples against SAG1 was analyzed 
by Western blot assays. Our results showed that chLiHsp83-SAG1 was recognized by IgG 
 antibodies in human serum samples from Toxoplasma-infected individuals, indicating that 
SAG1 fused to LiHsp83 can be recognized by antibodies under reducing condition. 
Although conformational epitopes were found in SAG1 protein [24, 57], the appreciable 
immunoreactivity of chLiHsp83-SAG1 observed in Western blots against positive sera, 
suggests that electrophoresis of proteins under reducing conditions makes the antigen react 
even if chLiHsp83-SAG1 is denatured. Recently, Velmurugan et al. [58] showed that 
recombinant non-folded SAG1 protein reacted with positive sera from goat, rabbit and 
humans by Western blot analysis. More recently, Cardona et al. [59] showed that, in 
humans, anti-SAG1 antibodies recognize lineal epitopes and they are directed mostly 
against peptides from the SAG1 carboxy-terminus. Additionally, Siachoque et al. [60] 
observed that the humoral response is specifically directed against these carboxy-terminus 
peptides in a murine model. In agree with these authors our results suggest that lineal 
epitopes of SAG1 would be recognized by IgG antibodies from Toxoplasma-infected 
humans.  
Finally, we evaluated the immunogenicity of LiHsp83-SAG1 expressed in 
chloroplasts. We previously showed that oral immunization with SAG1-expressing leaves 
did not elicit evident humoral immune responses and protection [27]. A heterologous 
protocol based on oral immunization with plant-derived SAG1 protein prior to rSAG1 
intradermal boost was necessary to elicit significant protection [27]. Here, the oral 
immunization with chLiHsp83-SAG1 elicited an important reduction of the cyst burden 
(~57% when compared to control) that correlated with an increased humoral response. Our 
results suggest that chLiHsp83-SAG1 retain the structural integrity to elicit immunological 
responses in mice. Although it remains to prove the efficacy of LiHsp83 as oral adjuvant in 
the antigen presentation, a potential for the use of LiHsp83 as an adjuvant for vaccine 
 antigens has been largely previously based on its immunomodulatory properties [32, 36]. In 
addition to this feature of LiHsp83, we demonstrate in the current study that LiHsp83 also 
enhances the solubility and expression of the SAG1 protein during antigen production.  
 
4.3 Conclusion 
We thus identify further applications of LiHsp83 properties that together with its 
immunomodulatory attributes, suggest LiHsp83 to be a promising candidate to function as 
a carrier protein for the expression of vaccine antigens in plants.  
We conclude that the fusion of recombinant proteins of interest to LiHsp83 is a 
novel strategy that presents advantages over other carrier proteins used in heterologous 
plant expression systems promoting the use of chloroplast transformation technology in 
molecular farming.  
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 Figure legends 
Figure 1: Chloroplast genome transformation with SAG1 and LiHsp83-SAG1 
sequences and morphological analysis of transplastomic plants. A: Schematic 
representation of chloroplast genome transformation. Map of the wild-type, SAG1 and 
LiHsp83-SAG1-transformed chloroplast genomes, the transgenes are positioned to the 
intergenic region between trnI and trnA. The SAG1 and LiHsp83-SAG1 expression cassette 
consists of the psbA promoter and 5-untranslated region (PpsbA) and the psbA terminator 
(TpsbA) from tobacco (Nicotiana tabacum cv. Petite Havana). The selectable marker gene 
aadA is driven by the ribosomal RNA operon promoter (Prrn). The expected sizes of DNA 
fragments in Southern blot analysis with the restriction enzyme BglII are indicated. The 
0.8-kb fragment (P1) of the targeting region for homologous recombination was used as 
probe for Southern blot analysis. B: Homoplasmy verification in transplastomic plantas. 
Southern blot analysis of two independent transplastomic lines for pAF-SAG1 and pAF-
LiHsp83-SAG1 constructions. The blots were probed with P1. WT ptDNA, wild-type 
chloroplast genome; Transplastomic ptDNA, SAG1 and LiHsp83-SAG1 transformed 
chloroplast genomes; DB, downstream box with the first 15 amino acids of the green 
ﬂuorescent protein; TD, tetramerisation domain from the human transcription factor p53 
with a C-terminal 7xHis-tag. C: Morphological analysis of SAG1 and LiHsp83-SAG1 
transplastomic plants (chSAG1 and chLiHsp83-SAG1, respectively). Growth retardation 
and chlorotic phenotype was observed within LiHsp83-SAG1 transplastomic plants. No 
overt morphological difference was observed in SAG1 transplastomic plants compared to 
wild-type (WT) tobacco plants.  
 
 Figure 2: Expression of chSAG1 protein in transplastomic tobacco plants. A: Western 
blot analysis of total protein extracts from mature leaves harvested 90 days after 
transplantation. The equivalent to 5 mg leaf fresh weight (25 µg of total proteins) per well 
were loaded in a 15% SDS-PAGE, transferred to PVDF membrane and immunoblotted 
with an anti-SAG1 polyclonal antibody Coomassie blue stained SDS-PAGE gel was used 
as a loading control. B: Quantiﬁcation of chSAG1 protein by Western blot. Total protein 
was extracted from chSAG1 lyophilized leaves harvested 90 days after transplantation. The 
equivalent to 5 mg of lyophilized tissue weight (250 µg of total proteins) per well were 
resolved by 15% SDS-PAGE, transferred to PVDF membrane and immunoblotted with an 
anti-SAG1 polyclonal antibody. A dilution series of puriﬁed E. coli-derived SAG1 (2, 4, 6, 
8 and 10 ng) was used as a reference for protein quantiﬁcation. The asterisk indicates a 
proteolytic product. chSAG1: transplastomic plant expressing SAG1 protein; EcS: 100 ng 
of E. coli-derived and purified SAG1 protein; WT: wild-type Nicotiana tabacum cv. Petite 
Havana, M:  molecular weight marker (Fermentas).  
 
Figure 3: Analysis of chLiHsp83-SAG1 fusion protein accumulation in transplastomic 
plants. A: Total protein extracts from mature leaves harvested 50, 75 and 100 days after 
transplantation (dat) were analyzed by coomassie blue-stained SDS-PAGE gel (upper 
panel) and by Western blot analysis of the same samples immunoblotted with an anti-SAG1 
polyclonal antibody (middle panel) or an anti-LiHsp83 polyclonal antibody (lower panel). 
The equivalent to 5 mg leaf fresh weight (25 µg of total protein per well) is shown with the 
chLiHsp83-SAG1 fusion protein resolving to form a 130-kDa band as indicated. B: 
chLiHsp83-SAG1 fusion protein expression in soluble (SF) and insoluble (InF) fractions. 
 Total soluble and insoluble proteins were extracted from mature leaves harvested 50 and 
100 days after transplantation (50 and 100, respectively) and resolved by SDS-PAGE and 
stained with coomassie blue. chLiHsp83-SAG1: transplastomic plant expressing LiHsp83-
SAG1 protein; WT: wild-type tobacco plant; RbcL: Ribulose bisphosphate carboxylase 
large subunit; M: molecular weight marker (Fermentas).  
 
Figure 4: Analysis of chLiHsp83-SAG1 accumulation in young, mature and old leaves 
of transplastomic plants. A: Coomassie blue-stained SDS-PAGE of young, mature and 
old leaves (YL, ML and OL, respectively). Total protein extracts from chLiHsp83-SAG1 
young, mature and old leaves harvested 100 days after transplanting. Twenty micrograms 
of plant total protein per well were resolved by 10% SDS-PAGE. B: Quantiﬁcation of 
LiHsp83-SAG1 fusion protein by Western blot. Total protein extracts were extracted from 
a pool of chLiHsp83-SAG1 mature and old leaves harvested 100 days after transplantation. 
Twenty micrograms of total plant protein was resolved by10% SDS-PAGE, transferred to 
PVDF membrane and immunoblotted with an anti-SAG1 or anti-LiHsp83 polyclonal 
antibody. A dilution series of puriﬁed E. coli-derived SAG1 (2, 4, 6, 8, 16 and 24 ng) and 
E. coli-derived LiHsp83 (10, 20, 40, 80 and 100 ng) were used as reference for protein 
quantiﬁcation. chLiHsp83-SAG1 protein migrates as a 130-kDa band. The asterisks 
indicate proteolytic degradation products. chLiHsp83-SAG1: transplastomic plant 
expressing LiHsp83-SAG1 protein; WT: wild-type tobacco plant; RbcL: Ribulose 
bisphosphate carboxylase large subunit; MW: molecular weight marker (Fermentas). 
 
Figure 5: Antigenic and immunogenic properties of SAG1 expressed in LiHsp83-
SAG1 transplastomic plantas. A: The reactivity of the recombinant chLiHsp83-SAG1 
 protein by IgG immunoblot assays. Leaf extract samples were separated by 10% SDS-
PAGE under reducing conditions. A: Immunoblot profiles of chLiHsp83-SAG1 leaf 
extracts were probed with human negative sera (1:100) (lanes 1–3), human Toxoplasma-
positive sera (1:100) (lanes 4–6), and rabbit anti-SAG1 polyclonal antibody (1:1000) (C+). 
B: Immunoblot profiles of wild-type leaf extracts probed with human Toxoplasma-positive 
sera (1:100) (lanes 4–6) and chLiHsp93-SAG1 leaf extracts probed with rabbit anti-SAG1 
polyclonal antibody (1:1000) (C+). The asterisks indicate the two bands that reacted with 
Toxoplasma-positive sera and rabbit anti-SAG1 polyclonal antibody. C: Immunoblot 
profiles of recombinant LiHsp83 (EcLiHsp83) probed with human Toxoplasma-positive 
sera (1:100) (lanes 4-6) and rabbit anti-LiHsp83 polyclonal antibody (1:1000) (C+). D: 
Protection assay after a challenge with T. gondii cysts in orally immunized C57BL/6(H-2d) 
mice. The results are showed as the cyst number per brain. E: Humoral response in orally 
immunized C57BL/6(H-2d) mice. Specific total anti-SAG1 IgGs (IgGt) in sera from 
vaccinated mice were determined by ELISA. Control: mice vaccinated with wild type leaf 
extracts, chLiHsp83-SAG1: mice vaccinated with transplastomic leaf extracts, PBS: mice 
vaccinated with PBS buffer. Statistical analysis was performed by one-way analysis of 
variance (ANOVA) using the Bonferroni’s Multiple Comparison Test. Different letters 
indicate significant differences among groups. a = p < 0.05. Results are expressed as the 
means value ± S.E.M. Values for each serum sample were determined in duplicate. 
  
  
  
  
 
 
  
  
 
  
  
